Aquestive Therapeutics Inc (NAS:AQST)
$ 3.27 0.18 (5.83%) Market Cap: 297.70 Mil Enterprise Value: 220.59 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Q1 2022 Aquestive Therapeutics Inc Earnings Call Transcript

May 04, 2022 / 12:00PM GMT
Release Date Price: $1.42 (+3.65%)
Operator

Good day, and thank you for standing by. I would now like to introduce your host for today's call, Bennett Watson. You may begin.

Bennett Watson;Westwicke;IR Associate

Thank you, operator. Good morning, and welcome to today's call. On today's call, I am joined by Keith Kendall, Chief Executive Officer; and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business developments and performance in the first quarter 2022, followed by a Q&A session.

As a reminder, the company's remarks today correspond with the earnings release that was issued after market close yesterday. In addition, a recording of today's call will be made available on Aquestive's website within the Investors section shortly following the conclusion of this call. To remind you, the Aquestive team will be discussing some non-GAAP financial measures this morning as part of its review of first quarter 2022 results. Description of these measures, along with a reconciliation to GAAP can be found in the earnings release issued

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot